166 related articles for article (PubMed ID: 28959610)
1. Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients.
Toure A; Cabral M; Niang A; Diop C; Garat A; Humbert L; Fall M; Diouf A; Broly F; Lhermitte M; Allorge D
Toxicol Rep; 2016; 3():826-831. PubMed ID: 28959610
[TBL] [Abstract][Full Text] [Related]
2. Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.
Zabost A; Brzezińska S; Kozińska M; Błachnio M; Jagodziński J; Zwolska Z; Augustynowicz-Kopeć E
Biomed Res Int; 2013; 2013():853602. PubMed ID: 24383060
[TBL] [Abstract][Full Text] [Related]
3. Correlation of N-acetyltransferase 2 genotype and acetylation status with plasma isoniazid concentration and its metabolic ratio in ethiopian tuberculosis patients.
Sileshi T; Telele NF; Burkley V; Makonnen E; Aklillu E
Sci Rep; 2023 Jul; 13(1):11438. PubMed ID: 37454203
[TBL] [Abstract][Full Text] [Related]
4. The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand.
Ungcharoen U; Sriplung H; Mahasirimongkol S; Chusri S; Wichukchinda N; Mokmued P; Wattanapokayakit S; Chongsuvivatwong V
Tuberc Respir Dis (Seoul); 2020 Dec; 83(Supple 1):S55-S62. PubMed ID: 33138342
[TBL] [Abstract][Full Text] [Related]
5. Study of NAT2 gene polymorphisms in an Indian population: association with plasma isoniazid concentration in a cohort of tuberculosis patients.
Singh N; Dubey S; Chinnaraj S; Golani A; Maitra A
Mol Diagn Ther; 2009; 13(1):49-58. PubMed ID: 19351215
[TBL] [Abstract][Full Text] [Related]
6. N-acetyltransferase gene polymorphisms & plasma isoniazid concentrations in patients with tuberculosis.
Hemanth Kumar AK; Ramesh K; Kannan T; Sudha V; Haribabu H; Lavanya J; Swaminathan S; Ramachandran G
Indian J Med Res; 2017 Jan; 145(1):118-123. PubMed ID: 28574024
[TBL] [Abstract][Full Text] [Related]
7. N-Acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients.
Kita T; Tanigawara Y; Chikazawa S; Hatanaka H; Sakaeda T; Komada F; Iwakawa S; Okumura K
Biol Pharm Bull; 2001 May; 24(5):544-9. PubMed ID: 11379777
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China.
Jing W; Zong Z; Tang B; Wang J; Zhang T; Wen S; Xue Y; Chu N; Zhao W; Huang H
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907179
[TBL] [Abstract][Full Text] [Related]
9. Study on Genotyping Polymorphism and Sequencing of N-Acetyltransferase 2 (NAT2) among Al-Ahsa Population.
Zahra MA; Kandeel M; Aldossary SA; Al-Taher A
Biomed Res Int; 2020; 2020():8765347. PubMed ID: 32626768
[TBL] [Abstract][Full Text] [Related]
10. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
[TBL] [Abstract][Full Text] [Related]
11. A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis.
Jung JA; Kim TE; Lee H; Jeong BH; Park HY; Jeon K; Kwon OJ; Ko JW; Choi R; Woo HI; Koh WJ; Lee SY
Drug Des Devel Ther; 2015; 9():5433-8. PubMed ID: 26491254
[TBL] [Abstract][Full Text] [Related]
12. Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships.
Ulanova V; Kivrane A; Viksna A; Pahirko L; Freimane L; Sadovska D; Ozere I; Cirule A; Sevostjanovs E; Grinberga S; Bandere D; Ranka R
Front Pharmacol; 2024; 15():1332752. PubMed ID: 38584604
[No Abstract] [Full Text] [Related]
13. The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid.
Donald PR; Parkin DP; Seifart HI; Schaaf HS; van Helden PD; Werely CJ; Sirgel FA; Venter A; Maritz JS
Eur J Clin Pharmacol; 2007 Jul; 63(7):633-9. PubMed ID: 17505821
[TBL] [Abstract][Full Text] [Related]
14. Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population.
Chen B; Shi HQ; Feng MR; Wang XH; Cao XM; Cai WM
Front Pharmacol; 2022; 13():932686. PubMed ID: 35928262
[No Abstract] [Full Text] [Related]
15. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
[TBL] [Abstract][Full Text] [Related]
16. NAT2 Genotypes in Moroccan Patients with Hepatotoxicity Due to Antituberculosis Drugs.
Guaoua S; Ratbi I; El Bouazzi O; Hammi S; Tebaa A; Bourkadi JE; Bencheikh RS; Sefiani A
Genet Test Mol Biomarkers; 2016 Nov; 20(11):680-684. PubMed ID: 27541622
[TBL] [Abstract][Full Text] [Related]
17. [Detection of mutation in NAT II gene as a method of determination of izoniazyd (INH) acetylation type in human population].
Augustynowicz-Kopeć E; Zabost A; Kozińska M; Brzezińska S; Zwolska Z
Pneumonol Alergol Pol; 2007; 75(2):134-9. PubMed ID: 17973219
[TBL] [Abstract][Full Text] [Related]
18. Arylamine
Doll MA; Salazar-González RA; Bodduluri S; Hein DW
Acta Pharm Sin B; 2017 Jul; 7(4):517-522. PubMed ID: 28752039
[TBL] [Abstract][Full Text] [Related]
19. Effects of N-acetyltransferase 2 (NAT2), CYP2E1 and Glutathione-S-transferase (GST) genotypes on the serum concentrations of isoniazid and metabolites in tuberculosis patients.
Fukino K; Sasaki Y; Hirai S; Nakamura T; Hashimoto M; Yamagishi F; Ueno K
J Toxicol Sci; 2008 May; 33(2):187-95. PubMed ID: 18544910
[TBL] [Abstract][Full Text] [Related]
20. Comparison between acetylator phenotype and genotype polymorphism of n-acetyltransferase-2 in tuberculosis patients.
Rana SV; Ola RP; Sharma SK; Arora SK; Sinha SK; Pandhi P; Singh K
Hepatol Int; 2012 Jan; 6(1):397-402. PubMed ID: 22020825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]